Heidi L. Wagner, Director at Wave Life Sciences Ltd. (WVE), sold 14,000 shares at $14.00 ($189K) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($189k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 7,000 | $91K | 48.1% |
| 2 | $14.00 | 7,000 | $98K | 51.9% |
| Total | $13.50 avg | 14,000 | $189K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $413K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $154K | — | Filing → |
| ALXN | SELL | 2017-10-04 | $17K | — | Filing → |